Silver Book Fact

The annual burden to the U.S. economy of age-related macular degeneration (AMD), cataract, diabetic retinopathy, glaucoma, refractive errors, visual impairment, and blindness in adults age 40 and older is estimated at $35.4 billion– $16.2 billion in direct medical costs, $11.1 billion in other direct costs, and $8 billion in lost productivity.

Rein D, Zhang P, Wirth K, Lee P, et al. The Economic Burden of Major Adult Visual Disorders in the United States. Arch Opthalmol. 2006; 124(12): 1754-60. http://archopht.ama-assn.org/cgi/content/abstract/124/12/1754

Reference

Title
The Economic Burden of Major Adult Visual Disorders in the United States
Publication
Arch Opthalmol
Publication Date
2006
Authors
Rein D, Zhang P, Wirth K, Lee P, et al
Volume & Issue
Volume 124, Issue 12
Pages
1754-60
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Annual Direct and Indirect Costs of Diabetic Retinopathy
     
  • Individuals with early-stage age-related macular degeneration (AMD) are almost 2 times more likely to have a stroke than those who do not have the eye disease.  
  • Blindness due to glaucoma
    Three out of four Americans that are legally blind due to glaucoma are over 65.  
  • Proportion of People with Diabetes with Diabetic Retinopathy of Any Severity, by Country
    Map figures are for both Type 1 and Type 2 diabetes.  
  • Nearly all patients with type 1 diabetes, and greater than 60% of patients with type 2, develop retinopathy within the first two decades of the disease.